1. How to use GuruFocus - Tutorials
  2. What Is in the GuruFocus Premium Membership?
  3. A DIY Guide on How to Invest Using Guru Strategies
Omar Venerio
Omar Venerio
Articles (1455) 

Nasdaq Rises, Fueled by Strong Results on Thursday

Celgene exceeds its bottom-line estimates

U.S. stock market indexes were in positive territory on Thursday, continuing the rally that followed the Federal Reserves' decision to maintain the interest rate of 2.25% to 2.5%. The Dow Jones Industrial Average fell 0.05% to 25,00, the S&P 500 index jumped 0.90% to 2,705 and the Nasdaq Composite Index rose 1.53% to 7,292.

Shares of Celgene Corp. (NASDAQ:CELG) inched up on Thursday morning after the company announced fourth-quarter results. Revenue grew 16.1% year over year to $4.04 billion, beating analysts' expectations by $50 million. Earnings were $2.39 per share, beating estimates by 7 cents.

“2018 was another year of excellent operating results and significant progress advancing our innovative early-, mid- and late-stage pipeline,” Chairman and CEO Mark J. Alles said.

In the fourth quarter, Revlimid sales rose 16% to $2.5 billion, sales of  Pomalyst/Imnovid grew 28% to $567 million, Otezla sales increased 21% to $448 million and Abraxane sales were $269 million, an increase of 7%.

Looking ahead to 2019, the company expects strong operating momentum, leading to double-digit top and bottom-line growth.

Gainers

Losers

Global markets

The main European stock markets were mixed. The U.K.'s FTSE 100 rose 0.39%, France's CAC 40 gained 0.36%, Germany's Dax declined 0.08% and Spain's IBEX 35 slid 0.16%.

In Asia, Japan's Nikkei 225 climbed 1.06%, India’s BSE Sensex advanced 1.87%, Hong Kong's Hang Seng jumped 1.08% and China's Shanghai Composite inched up 0.35%.

Disclosure: The author holds no positions in any stocks mentioned.

About the author:

Omar Venerio
Omar Venerio is a capital markets, derivatives, corporate finance and financial management professor. He is passionate about the stock market and providing independent fundamental research and hedge fund and insider trading-focused investigation.

Rating: 0.0/5 (0 votes)

Comments

Please leave your comment:


Performances of the stocks mentioned by Omar Venerio


User Generated Screeners


pjmason14Momentum
pascal.van.garsseHigh FCF-M2
kosalmmuse6
kosalmmuseBest one1
DBrizanall 2019Feb26
kosalmmuseBest one
DBrizanall 2019Feb25
kosalmmuseNice
kosalmmusehan
MsDale*52-Week Low
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}
FEEDBACK